Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Hyperammonemia and encephalopathy in patients with multiple myeloma.

Talamo G, Cavallo F, Zangari M, Barlogie B, Lee CK, Pineda-Roman M, Kiwan E, Krishna S, Tricot G.

Am J Hematol. 2007 May;82(5):414-5. No abstract available.

2.

Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.

Pham A, Reagan JL, Castillo JJ.

Leuk Res. 2013 Oct;37(10):1229-32. doi: 10.1016/j.leukres.2013.07.014. Epub 2013 Aug 6. Review.

PMID:
23932549
3.

Noncirrhotic hyperammonaemic encephalopathy.

Laish I, Ben Ari Z.

Liver Int. 2011 Oct;31(9):1259-70. doi: 10.1111/j.1478-3231.2011.02550.x. Epub 2011 Jun 21. Review.

PMID:
21745294
4.

[Clinicopathological study of multiple myeloma associated with hyperammonemia].

Fujii S, Fukuda S, Sezaki T, Murakami M.

Rinsho Ketsueki. 1998 Jan;39(1):27-33. Review. Japanese.

PMID:
9492550
5.

Hyperammonemic encephalopathy.

Brusilow SW.

Medicine (Baltimore). 2002 May;81(3):240-9. Review. No abstract available.

6.

Hyperammonemia, bane of the brain.

Cohn RM, Roth KS.

Clin Pediatr (Phila). 2004 Oct;43(8):683-9. Review.

PMID:
15494874
7.

[Hyperammonemia type II as an example of urea cycle disorder].

Hawrot-Kawecka AM, Kawecki GP, Duława J.

Wiad Lek. 2006;59(7-8):512-5. Review. Polish.

PMID:
17209350
8.

[Multiple myeloma with hyperammonemia].

Izumi T.

Ryoikibetsu Shokogun Shirizu. 1998;(22 Pt 3):446-8. Review. Japanese. No abstract available.

PMID:
9851186
9.

Hyperammonemia-induced toxicity for the developing central nervous system.

Cagnon L, Braissant O.

Brain Res Rev. 2007 Nov;56(1):183-97. Epub 2007 Aug 15. Review.

PMID:
17881060
10.

On the reversibility of glutamate dehydrogenase and the source of hyperammonemia in the hyperinsulinism/hyperammonemia syndrome.

Treberg JR, Brosnan ME, Watford M, Brosnan JT.

Adv Enzyme Regul. 2010;50(1):34-43. doi: 10.1016/j.advenzreg.2009.10.029. Epub 2009 Nov 4. Review. No abstract available.

PMID:
19895831
11.
12.

[Disturbances in ammonia metabolism in hepatic failure].

Ytrebø LM.

Tidsskr Nor Laegeforen. 2007 May 31;127(11):1514-7. Review. Norwegian.

13.

[Dialysis encephalopathy].

Luciak M.

Pol Tyg Lek. 1981 Apr 13;36(15):541-3. Review. Polish. No abstract available.

PMID:
7024944
14.

[Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].

Fassi G, Igoa A, Liste OA.

Vertex. 2008 Nov-Dec;19(82):371-7. Review. Spanish.

PMID:
19424520
15.

[Hyperammonemia: causes, diagnosis and therapy. 2. Symptoms and therapy].

Häberle J, Koch HG.

Dtsch Med Wochenschr. 2004 Jun 18;129(25-26):1430-3. Review. German. No abstract available.

PMID:
15213875
16.

Valproate-associated hyperammonemic encephalopathy.

Wadzinski J, Franks R, Roane D, Bayard M.

J Am Board Fam Med. 2007 Sep-Oct;20(5):499-502. Review.

17.

[Uremic encephalopathy, uremic coma].

Maeda K.

Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):66-8. Review. Japanese. No abstract available.

PMID:
9277686
18.

[Dialysis encephalopathy and dialysis dementia].

Marumo F.

Ryoikibetsu Shokogun Shirizu. 1997;(17 Pt 2):107-10. Review. Japanese. No abstract available.

PMID:
9277872
19.

Hyperviscosity syndrome in patients with multiple myeloma.

Mullen E, Mendez N.

Oncol Nurs Forum. 2008 May;35(3):350-2. doi: 10.1188/08.ONF.350-352. Review. No abstract available.

PMID:
18467286
20.

Supplemental Content

Support Center